[go: up one dir, main page]

AR112096A1 - Una composición inhibidora de la melanogénesis - Google Patents

Una composición inhibidora de la melanogénesis

Info

Publication number
AR112096A1
AR112096A1 ARP180101605A ARP180101605A AR112096A1 AR 112096 A1 AR112096 A1 AR 112096A1 AR P180101605 A ARP180101605 A AR P180101605A AR P180101605 A ARP180101605 A AR P180101605A AR 112096 A1 AR112096 A1 AR 112096A1
Authority
AR
Argentina
Prior art keywords
melanogenesis
combination
inhibiting composition
hydroxybenzylidene
propan
Prior art date
Application number
ARP180101605A
Other languages
English (en)
Inventor
Cassie Fhaner
Yujing Tan
Kinjalbahen Joshi
Original Assignee
Dow Global Technologies Llc
Rohm & Haas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Global Technologies Llc, Rohm & Haas filed Critical Dow Global Technologies Llc
Publication of AR112096A1 publication Critical patent/AR112096A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/10—General cosmetic use

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Combinación inhibidora de la melanogénesis, que comprende: una combinación de óxido de (Z)-N-(4-hidroxibenciliden)propan-2-amina; y un compuesto de la fórmula (1), en donde R¹ y R² se seleccionan, de modo independiente, de un átomo de hidrógeno y un grupo acilo que tiene 3 a 20 átomos de carbono; en donde la combinación se dispersa en un portador dermatológicamente aceptable.
ARP180101605A 2017-06-27 2018-06-12 Una composición inhibidora de la melanogénesis AR112096A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201762525309P 2017-06-27 2017-06-27

Publications (1)

Publication Number Publication Date
AR112096A1 true AR112096A1 (es) 2019-09-18

Family

ID=62749222

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP180101605A AR112096A1 (es) 2017-06-27 2018-06-12 Una composición inhibidora de la melanogénesis

Country Status (8)

Country Link
US (1) US20200289392A1 (es)
EP (1) EP3644947A1 (es)
JP (1) JP2020525406A (es)
CN (1) CN110769808A (es)
AR (1) AR112096A1 (es)
BR (1) BR112019025648A2 (es)
TW (1) TW201904567A (es)
WO (1) WO2019005437A1 (es)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2565513B2 (ja) * 1987-09-25 1996-12-18 三省製薬株式会社 メラニン生成抑制外用薬剤
BR112014012941B1 (pt) * 2011-11-30 2019-04-09 Dow Global Technologies Llc Composição para cuidado pessoal, método cosmético para tratar pele, e, métodos para inibir a degradação de colágeno na pele e para reduzir os sinais visíveis de envelhecimento

Also Published As

Publication number Publication date
BR112019025648A2 (pt) 2020-08-25
EP3644947A1 (en) 2020-05-06
WO2019005437A1 (en) 2019-01-03
TW201904567A (zh) 2019-02-01
CN110769808A (zh) 2020-02-07
US20200289392A1 (en) 2020-09-17
JP2020525406A (ja) 2020-08-27

Similar Documents

Publication Publication Date Title
JO3261B1 (ar) مشتق بيريدين أحادي الحلقة
GEAP202215378A (en) Microbiocidal thiazole derivatives
EA202091893A1 (ru) Новые кристаллические формы
AR099376A1 (es) Compuestos de diaminopirimidilo sustituidos, sus composiciones y métodos de tratamiento con aquellos
CO2018010787A2 (es) Compuesto de griseofulvina
MX383051B (es) Compuestos que inhiben eif4a y métodos relacionados a los mismos.
ECSP088812A (es) Derivados de dihidropirazolopirimidinona
SA515361086B1 (ar) Fasn مركبات وتركيبات جديدة لتثبيط
AR060545A1 (es) Compuestos de benzoaxol y benzotiazol 6-0- sustituidos y metodos de inhibicion de la senalizacion de csf-1r. composiciones farmaceuticas
CL2012000311A1 (es) Compuestos derivados que contiene ciclos con 3 atomos de nitrogeno; utiles en el tratamiento de parasitosis en animales.
MX394836B (es) Derivado de anillo fusionado que tiene una actividad inhibidora de monoacilglicerol aciltransferasa 2 (mgat-2)
NZ709986A (en) Pharmaceutical compositions comprising nitroxyl donors
PH12020552152A1 (en) Novel pyridine and pyrazine compounds as inhibitors of cannabinoid receptor 2
MX391647B (es) Derivados heterociclicos de seis miembros y composicion farmaceutica que los comprende.
BR112015019437A2 (pt) complexo de bis(2-indenil) metaloceno
PH12012501385A1 (en) Piperazine compound having a pgds inhibitory effect
FR3066761B1 (fr) Nouveaux composes inhibiteurs des canaux ioniques
MX2016017405A (es) Compuestos derivados de 2-(3-piridinil)-1h-benzimidazol y medicamentos que los contienen.
FR2973230B1 (fr) Utilisation de gingerone ou de ses derives pour diminuer ou retarder les signes du vieillissement de la peau
MA55593A (fr) Cycles pyridine contenant des dérivés servant d'inhibiteurs de malt1
DOP2018000134A (es) Compuestos de 1,3,4-tiadiazol y su uso en el tratamiento del cáncer
PH12015502851A1 (en) Curable composition
AR112096A1 (es) Una composición inhibidora de la melanogénesis
MX2020012483A (es) Agente de aclaramiento de la piel.
SG11201811541TA (en) Composition for removing iron sulfide

Legal Events

Date Code Title Description
FB Suspension of granting procedure